VIM and small cell lung carcinoma: The CD8+ TIL low/Vimentin(+) tumors (6 out of 90 SCLC patients corresponding to 6.7% of the cohort) can be classified as SCLC-M with an elevated EMT signature but lack of immune cell infiltration, compared with SCLC-I with elevated immune cell infiltration.